RESOLUTE ONCOLOGY INC Financing Cash Flow
RESOLUTE ONCOLOGY INC reported Financing Cash Flow of $2.60 million for the 51-month period ending 2013-09-30, per its 10-Q filed 2013-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2013-11-14
- RESOLUTE ONCOLOGY INC net cash provided by (used in) financing activities for the quarter ending 2013-09-30 was $175.00K, a 2436.23% increase year-over-year.
- RESOLUTE ONCOLOGY INC net cash provided by (used in) financing activities for the quarter ending 2013-06-30 was $350.00K, a 2539.52% increase year-over-year.
- RESOLUTE ONCOLOGY INC net cash provided by (used in) financing activities for the quarter ending 2013-03-31 was $1.49M, a 26620.43% increase year-over-year.
- RESOLUTE ONCOLOGY INC net cash provided by (used in) financing activities for the quarter ending 2012-12-31 was $1.71M, a 31253.14% increase year-over-year.
- RESOLUTE ONCOLOGY INC net cash provided by (used in) financing activities for fiscal 2012 was $1.74M, a 11305.09% increase from fiscal 2011.
- RESOLUTE ONCOLOGY INC net cash provided by (used in) financing activities for fiscal 2011 was $15.22K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 33 month | Net Cash Provided by (Used in) Financing Activities 36 month | Net Cash Provided by (Used in) Financing Activities 39 month | Net Cash Provided by (Used in) Financing Activities 45 month | Net Cash Provided by (Used in) Financing Activities 48 month | Net Cash Provided by (Used in) Financing Activities 51 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $525.00K derived: sum of 2 quarters · filed 2013-11-14 | $2.02M 10-Q · filed 2013-11-14 | $3.73M derived: sum of 4 quarters · filed 2013-11-14 | $2.60M 10-Q · filed 2013-11-14 | |||||
| 2013-06-30 | $350.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | $1.84M 10-Q · filed 2013-08-19 | $3.55M derived: sum of 3 quarters · filed 2013-08-19 | $3.56M derived: sum of 4 quarters · filed 2013-11-14 | $2.43M 10-Q · filed 2013-08-19 | |||||
| 2013-03-31 | $1.49M 10-Q · filed 2013-05-17 | $3.20M derived: sum of 2 quarters · filed 2013-05-17 | $3.21M derived: sum of 3 quarters · filed 2013-11-14 | $3.22M derived: sum of 4 quarters · filed 2013-11-14 | $2.08M 10-Q · filed 2013-05-17 | |||||
| 2012-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.72M derived: sum of 2 quarters · filed 2013-11-14 | $1.73M derived: sum of 3 quarters · filed 2013-11-14 | $1.74M 10-K · filed 2013-03-28 | $1.79M 10-K · filed 2013-03-28 | |||||
| 2012-09-30 | $6.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $20.16K derived: sum of 2 quarters · filed 2013-11-14 | $25.74K 10-Q · filed 2013-11-14 | $31.19K derived: sum of 4 quarters · filed 2013-11-14 | $82.17K 10-Q · filed 2012-11-01 | |||||
| 2012-06-30 | $13.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | $18.84K 10-Q · filed 2013-08-19 | $24.29K derived: sum of 3 quarters · filed 2013-08-19 | $31.89K derived: sum of 4 quarters · filed 2013-08-19 | $75.27K 10-Q/A · filed 2012-08-21 | |||||
| 2012-03-31 | $5.58K 10-Q · filed 2013-05-17 | $11.03K derived: sum of 2 quarters · filed 2013-05-17 | $18.63K derived: sum of 3 quarters · filed 2013-05-17 | $62.01K 10-Q/A · filed 2012-09-10 | ||||||
| 2011-12-31 | $5.45K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $13.04K derived: sum of 2 quarters · filed 2013-03-28 | $15.22K 10-K · filed 2013-03-28 | |||||||
| 2011-09-30 | $7.59K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-01 | $9.77K 10-Q · filed 2012-11-01 | ||||||||
| 2011-06-30 | $2.17K 10-Q/A · filed 2012-08-21 |